CurrentBlue Cross Blue Shield - MassachusettsPolicy 493

Breast duct endoscopy (mammary ductoscopy) — Coverage Criteria

This policy governs coverage and authorization requirements for breast duct endoscopy for Blue Cross Blue Shield of Massachusetts members, specifying that the procedure is considered investigational and outlining outpatient/inpatient authorization rules and coverage stance.

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

PolicyBreast duct endoscopy (mammary ductoscopy) — Coverage Criteria

Policy CodePolicy 493

Change TypeNo material change

Effective Date

Next Review Date

Key ActionObtain precertification/preauthorization when the procedure is performed inpatient; outpatient procedures are not covered for specified products.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

InvestigationalCoverage stance for breast duct endoscopy

Precertification requiredInpatient authorization

Not covered outpatientOutpatient coverage status

No specific CPT codeCoding note

Sept 2022

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Determination

Investigational / Not established as medically necessary

Covered when ALL of the following are met

Investigational stance: Breast duct endoscopy is considered investigational because its impact on health outcomes is uncertain.

The majority of published studies are uncontrolled case series or retrospective studies; evidence is insufficient to establish clinical benefit.

Description: Breast duct endoscopy (mammary ductoscopy) is a technique that provides direct visual examination of the breast ducts through nipple orifice cannulation and exploration.

Investigated uses include evaluation of spontaneous nipple discharge, obtaining cellular material for cancer risk stratification, delineation of intraductal disease margins, follow-up after atypical cytology, and direct intraductal therapeutic delivery.

For outpatient settings, breast duct endoscopy (mammary ductoscopy) is not a covered service for the following products: Commercial Managed Care (HMO and POS), Commercial PPO and Indemnity, Medicare HMO BlueSm, and Medicare PPO BlueSm. Claims for outpatient procedures in these products may be denied. Precertification/preauthorization is required if the procedure is performed inpatient; authorization requirements for outpatient services vary by product but do not override the outpatient noncoverage statement above.

Breast duct endoscopy is designated investigational because the available literature is predominantly uncontrolled case series and retrospective studies, and the procedure’s effect on meaningful health outcomes remains uncertain. As a result, the procedure is not considered medically necessary.

Coding and Billing

Covered CPT CodesCPT

No codes listed

No specific CPT codeCPT

No codes listed

Provider Requirements and Billing Guidance

Prior Authorization

Prior Authorization Required

Precertification/preauthorization is required when breast duct endoscopy is performed inpatient. Check member product rules for outpatient procedures — authorization may be required for some products.

When performed inpatient: precertification/preauthorization required for all products.
When performed outpatient: authorization may be required depending on product (see denial risk below for specifics).

Note

Provider Action

Action: Verify prior authorization requirements and confirm coverage status with the member's product before scheduling the procedure.

Background

Breast duct endoscopy, also called mammary ductoscopy, is a technique that provides direct visual examination of the breast ducts by cannulating the nipple orifice and advancing an endoscope to inspect intraductal epithelium. It has been investigated as a diagnostic alternative in patients with spontaneous nipple discharge, for obtaining cellular material for risk assessment, delineating intraductal disease margins, follow-up after atypical cytology, and as a route for intraductal therapeutic delivery.

Definitions

Breast duct endoscopy / mammary ductoscopy — definition and uses

TermBreast duct endoscopy (mammary ductoscopy)

DefinitionA technique that provides direct visual examination of the breast ducts through nipple orifice cannulation and exploration.

Clinical uses investigatedEvaluation of spontaneous nipple discharge as a potential alternative to surgical excision; obtaining cellular material for breast cancer risk stratification; delineation of intraductal disease to define surgical margins; follow-up after atypical cytology detected by ductal lavage.

Therapeutic applications under studyDirect intraductal delivery of agents (e.g., photodynamic therapy, laser ablation, topical biological agents).

Status summaryProcedure remains investigational due to uncertain impact on health outcomes (see coverage criteria).